Natera Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -99.41. In total, the insiders bought 26.51K and sold 188.11K NTRA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-99.41
Buy 26.51K shares
Sell 188.11K shares
5% Buy Activity
Moderate Negative Correlation
Sell Signal High Confidence
Jan 20, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -99.41.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming sell-side pressure (5% buys).

Historical Insider Trades

Date Type Person Role Amount
May 08, 2026
Sell
Common Stock
S-Sale
Sheena Jonathan
Co-founder
Director 1 150
Value: $241.9K
May 05, 2026
Sell
Common Stock
S-Sale
Rabinowitz Matthew
Executive Chairman
CEO / President 1 454
Value: $351.0K
May 05, 2026
Sell
Common Stock
S-Sale
Rabinowitz Matthew
Executive Chairman
CEO / President 948
Value: $194.5K
May 05, 2026
Sell
Common Stock
S-Sale
Rabinowitz Matthew
Executive Chairman
CEO / President 1 697
Value: $350.9K
May 05, 2026
Buy
Common Stock
A-Award
Rabinowitz Matthew
Executive Chairman
CEO / President 2 389
Value: $494.0K
May 05, 2026
Sell
Common Stock
S-Sale
Rabinowitz Matthew
Executive Chairman
CEO / President 2 887
Value: $596.9K
May 04, 2026
Sell
Common Stock
S-Sale
Rabinowitz Matthew
Executive Chairman
CEO / President 722
Value: $148.8K
May 04, 2026
Sell
Common Stock
S-Sale
Brophy Michael Burkes
Chief Financial Officer
C-Suite Officer 482
Value: $101.5K
May 01, 2026
Sell
Common Stock
S-Sale
Moshkevich Solomon
President, Clinicaldiagnostics
CEO / President 405
Value: $83.5K
May 01, 2026
Sell
Common Stock
S-Sale
Sheena Jonathan
Co-founder
Director 107
Value: $22.1K
May 01, 2026
Sell
Common Stock
S-Sale
Brophy Michael Burkes
Chief Financial Officer
C-Suite Officer 313
Value: $64.5K
May 01, 2026
Sell
Common Stock
S-Sale
Moshkevich Solomon
President, Clinicaldiagnostics
CEO / President 520
Value: $104.8K
May 01, 2026
Sell
Common Stock
S-Sale
Moshkevich Solomon
President, Clinicaldiagnostics
CEO / President 560
Value: $112.5K
May 01, 2026
Sell
Common Stock
S-Sale
Rabinowitz Daniel
Sec. And Chief Legal Officer
Officer 330
Value: $68.0K
May 01, 2026
Sell
Common Stock
S-Sale
Chapman Steven Leonard
CEO And President
CEO / President 902
Value: $186.0K
May 01, 2026
Sell
Common Stock
S-Sale
Fesko John
President, Chief Bus. Officer
CEO / President 291
Value: $60.0K
May 01, 2026
Sell
Common Stock
S-Sale
Moshkevich Solomon
President, Clinicaldiagnostics
CEO / President 150
Value: $31.0K
May 01, 2026
Sell
Common Stock
S-Sale
Moshkevich Solomon
President, Clinicaldiagnostics
CEO / President 400
Value: $82.1K
May 01, 2026
Sell
Common Stock
S-Sale
Moshkevich Solomon
President, Clinicaldiagnostics
CEO / President 865
Value: $176.9K
May 01, 2026
Sell
Common Stock
S-Sale
Moshkevich Solomon
President, Clinicaldiagnostics
CEO / President 505
Value: $102.7K
Apr 29, 2026
Sell
Common Stock
S-Sale
Brophy Michael Burkes
Chief Financial Officer
C-Suite Officer 1 070
Value: $208.5K
Apr 29, 2026
Sell
Common Stock
S-Sale
Brophy Michael Burkes
Chief Financial Officer
C-Suite Officer 1 000
Value: $193.8K
Apr 29, 2026
Sell
Common Stock
S-Sale
Brophy Michael Burkes
Chief Financial Officer
C-Suite Officer 500
Value: $96.1K
Apr 29, 2026
Sell
Common Stock
S-Sale
Brophy Michael Burkes
Chief Financial Officer
C-Suite Officer 300
Value: $57.0K
Apr 27, 2026
Sell
Common Stock
S-Sale
Brophy Michael Burkes
Chief Financial Officer
C-Suite Officer 1 222
Value: $249.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT NATERA
Natera
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; a...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
OSW
$24.00
17.08% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE